Critical Review: Amarillo Biosciences (OTCMKTS:AMAR) and Eastman Kodak (NYSE:KODK)

Amarillo Biosciences (OTCMKTS:AMAR) and Eastman Kodak (NYSE:KODK) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Profitability

This table compares Amarillo Biosciences and Eastman Kodak’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Amarillo Biosciences	-41,453.98%	N/A	-574.29%
Eastman Kodak	-8.28%	-14.47%	-5.55%

Volatility and Risk

Amarillo Biosciences has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500. Comparatively, Eastman Kodak has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Amarillo Biosciences and Eastman Kodak, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amarillo Biosciences	0	0	0	0	0.00
Eastman Kodak	1	0	0	0	1.00

Given Amarillo Biosciences’ higher possible upside, equities analysts clearly believe Amarillo Biosciences is more favorable than Eastman Kodak.

Earnings and Valuation

This table compares Amarillo Biosciences and Eastman Kodak”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amarillo Biosciences	$20,000.00	0.00	-$1.45 million	N/A	N/A
Eastman Kodak	$1.07 billion	0.92	-$128.00 million	($1.39)	-7.21

Amarillo Biosciences has higher earnings, but lower revenue than Eastman Kodak.

Institutional and Insider Ownership

33.6% of Eastman Kodak shares are held by institutional investors. 34.4% of Amarillo Biosciences shares are held by company insiders. Comparatively, 21.3% of Eastman Kodak shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Eastman Kodak beats Amarillo Biosciences on 6 of the 10 factors compared between the two stocks.

About Amarillo Biosciences

Amarillo Biosciences, Inc., a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases. The Medical division focuses on medical devices and developing technology to treat metabolism related diseases, such as Type 1 and Type 2 diabetes. The Consumer division provides a range of nutraceutical and food supplement products that utilize a liposomal delivery system. It owns four issued patents related to the low-dose oral delivery of interferon; one patent is for a product promoting oral health; and three patents are associated with treatment of metabolic disorders. The company was incorporated in 1984 and is based in Amarillo, Texas.

About Eastman Kodak

Eastman Kodak Company engages in the provision of hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through three segments: Print, Advanced Materials and Chemicals, and Brand. The Print segment provides digital offset plate offerings and computer-to-plate imaging solutions; press systems and components under the PROSPER brand name, as well as print inks and primers under the KODAK OPTIMAX, KODACHROME, and KODAK EKTACOLOR brand names; and PRINERGY, a workflow production software, which is used by customers to manage digital and conventional print content from file creation to output. This segment offers its products to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, décor, and packaging/labels. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, advanced materials and functional printing, and IP licensing and analytical activities. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. The company is also involved in the operation of Eastman Business Park, a technology center and industrial complex. It sells its products and services through direct sales, third party resellers, dealers, channel partners, and distributors. The company was founded in 1880 and is headquartered in Rochester, New York.